Study to understand usage and effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

Trial Identifier: D1680R00019
Sponsor: AstraZeneca
NCTID:: NCT02588859
Start Date: October 2015
Primary Completion Date: December 2016
Study Completion Date: December 2016
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
INDIA, Andhra Pradesh Nellure, Andhra Pradesh, INDIA
INDIA, Andhra Pradesh Vishakhapatnam, Andhra Pradesh, INDIA
INDIA, Assam Guwahati, Assam, INDIA
INDIA, Delhi New Delhi, Delhi, INDIA
INDIA, Gujarat Ahmedabad, Gujarat, INDIA
INDIA, Gujarat Rajkot, Gujarat, INDIA
INDIA, Gujarat Vadodara, Gujarat, INDIA
INDIA, Haryana Karnal, Haryana, INDIA
INDIA, Haryana Yamunanagar, Haryana, INDIA
INDIA, Karnataka Bangalore, Karnataka, INDIA
INDIA, Kerala Trivandrum, Kerala, INDIA
INDIA, Kochi Cochin, Kochi, INDIA
INDIA, Madhya Pradesh Bhopal, Madhya Pradesh, INDIA
INDIA, Madhya Pradesh Indore, Madhya Pradesh, INDIA
INDIA, Maharashtra Mumbai, Maharashtra, INDIA
INDIA, Maharashtra Pune, Maharashtra, INDIA
INDIA, New Delhi new Delhi, New Delhi, INDIA
INDIA, Punjab Amritsar, Punjab, INDIA
INDIA, Punjab Chandigarh, Punjab, INDIA
INDIA, Punjab Ludhiana, Punjab, INDIA
INDIA, Rajasthan Jaipur, Rajasthan, INDIA
INDIA, Rajasthan Udaipur, Rajasthan, INDIA
INDIA, Tamiladu Madurai, Tamiladu, INDIA
INDIA, Tamilnadu chennai, Tamilnadu, INDIA
INDIA, Tamilnadu Chennai, Tamilnadu, INDIA
INDIA, Telangana Hyderabad, Telangana, INDIA
INDIA, Telangana Hyderebad, Telangana, INDIA
INDIA, Uttar Pradesh Allahabad, Uttar Pradesh, INDIA
INDIA, Uttar Pradesh Kanpur, Uttar Pradesh, INDIA
INDIA, Uttar Pradesh Lucknow, Uttar Pradesh, INDIA
INDIA, Uttar Pradesh Noida, Uttar Pradesh, INDIA
INDIA, West Bengal Kolkata, West Bengal, INDIA